Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients With Acute Respiratory Distress Syndrome (ARDS)

NCT04355728 is registered in ClinicalTrials.gov with Camillo Ricordi as lead sponsor.

NCT NCT04355728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04355728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients With Acute Respiratory Distress Syndrome (ARDS)
Lead sponsor
Camillo Ricordi
Phase
Phase 1/2
Overall status
Completed
Start date
April 25, 2020
Completion date
October 31, 2020
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, ards, ards, human, corona virus infection, covid-19